Publications by authors named "Christopher E Griffiths"

Claim this Profile
D
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove.
Teresa Tsakok, Jake Saklatvala, Theo Rispens, Floris C Loeff, Annick de Vries, Christopher Em Griffiths

JCI Insight· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK: results from two matched case-control studies.
Maha Abo-Tabik, Rosa Parisi, Catharine Morgan, Sarah Willis, Christopher Em Griffiths

Br J Gen Pract· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The systemic influence of chronic smoking on skin structure and mechanical function.
Abigail K Langton, Evridiki Tsoureli-Nikita, Holly Merrick, Xuegen Zhao, Christina Antoniou, Christopher Em Griffiths

J Pathol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials.
Andrew F. Alexis, Marta Rendon, Jonathan I. Silverberg, David M. Pariser, Benjamin Lockshin, Christopher E.M. Griffiths

J Drugs Dermatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WITHDRAWN: Interventions for guttate psoriasis.
Robert Chalmers, Teresa O'Sullivan, Caroline M Owen, Christopher Em Griffiths

Cochrane Database Syst Rev· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WITHDRAWN: Antistreptococcal interventions for guttate and chronic plaque psoriasis.
Caroline M Owen, Robert Chalmers, Teresa O'Sullivan, Christopher Em Griffiths

Cochrane Database Syst Rev· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical applications of machine learning algorithms: beyond the black box.
David S Watson, Jenny Krutzinna, Ian N Bruce, Christopher Em Griffiths, Iain B McInnes

BMJ· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study.
Christopher Em Griffiths, Linda Stein Gold, Frédéric Cambazard, Robert E Kalb, David Lowson

Eur J Dermatol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis.
Siao Pei Tan, Simon B Brown, Christopher Em Griffiths, Richard B Weller, Neil K Gibbs

Clin Cosmet Investig Dermatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of IL-17A by secukinumab shows no evidence of increased infections.
Michael Kammüller, Tsen-Fang Tsai, Christopher Em Griffiths, Nidhi Kapoor, Pappachan E Kolattukudy

Clin Transl Immunology· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review.
Alasdair L Henry, Simon D Kyle, Sahil Bhandari, Anna Chisholm, Christopher E M Griffiths

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial.
Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, Bruce Randazzo, Yasmine Wasfi

J Am Acad Dermatol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenges of assessing patients' medication beliefs: a qualitative study.
Rachael J Thorneloe, Christopher E M Griffiths, Darren M Ashcroft, Lis Cordingley

BMC Health Serv Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study assessing pathophysiology and healing of digital ulcers in patients with systemic sclerosis using laser Doppler imaging and thermography.
Andrea K Murray, Tonia L Moore, Elizabeth Wragg, Holly Ennis, Andy Vail, Christopher E M Griffiths

Clin Exp Rheumatol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis and Atopic Dermatitis.
Christopher E M Griffiths, Peter van de Kerkhof, Magdalena Czarnecka-Operacz

Dermatol Ther (Heidelb)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 17-A inhibition in the treatment of psoriasis.
Zenas Z N Yiu, Christopher E M Griffiths

Expert Rev Clin Immunol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis.
Peter C M van de Kerkhof, Christopher E M Griffiths, Kristian Reich, Craig L Leonardi, Andrew Blauvelt

J Am Acad Dermatol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel systemic therapies for the treatment of psoriasis.
Ki-Wei Tan, Christopher E M Griffiths

Expert Opin Pharmacother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive Imaging of Localised Scleroderma for Assessment of Skin Blood Flow and Structure.
Andrea K Murray, Tonia L Moore, Joanne B Manning, Graham Dinsdale, Jack Wilkinson, Christopher E M Griffiths

Acta Derm Venereol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of intrinsic ageing on the protein composition of the dermal-epidermal junction.
Abigail K Langton, Poonam Halai, Christopher E M Griffiths, Michael J Sherratt, Rachel E B Watson

Mech Ageing Dev· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Communicating Cardiovascular Disease Risk to People with Psoriasis: What Techniques do Practitioners Use?
Chris Keyworth, Pauline A Nelson, Carolyn A Chew-Graham, Karen Kane, Christina J Pearce, Christopher E M Griffiths

Int J Behav Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options.
Ulrike Blume-Peytavi, Jan Kottner, Wolfram Sterry, Michael W Hodin, Tamara W Griffiths, Christopher E M Griffiths

Gerontologist· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis.
Paul Devakar Yesudian, Joyce Leman, Periasamy Balasubramaniam, Andy W Macfarlane, Firas Al-Niaimi, Christopher E M Griffiths

J Drugs Dermatol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixekizumab for psoriasis--Authors' reply.
Christopher E M Griffiths, Kim A Papp, Susan G Ball, Brian J Nickoloff

Lancet· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis